Senior Scientist, Systems Immunology
Immunai
Summary
We seek an exceptionally motivated Senior Scientist, Systems Immunologist to join our team of talented researchers in a highly collaborative startup environment at the intersection of immunology, AI, and new genomic technologies. This position offers an opportunity to work on a diverse set of projects related to human immunology, with a focus on cancer immunology and autoimmunity, in support of multiple projects.
Job description
About the role
We seek an exceptionally motivated Senior Scientist, Systems Immunologist to join our team of talented researchers in a highly collaborative startup environment at the intersection of immunology, AI, and new genomic technologies. This position offers an opportunity to work on a diverse set of projects related to human immunology, with a focus on cancer immunology and autoimmunity, in support of multiple projects.
What will you do?
- Serve as an immunology subject-matter expert on internal and external collaboration projects.
- Utilize your computational skills as part of the External Collaborations dry lab team (Systems Immunologists & Computational Biologists).
- Independently contribute to project planning, including goals, activities, and timelines
- Lead the translation of data analysis to biological insights with the goal of generating actionable recommendations to inform drug development
- Take an active role in shaping Immunai's bioinformatic platforms to reflect immunological insights
- Clearly communicate concepts and findings to external stakeholders in the form of presentations and data reports
- Perform literature reviews to establish and maintain a deep understanding of project-specific immunological concepts, and simultaneously maintain a broad understanding of the most current updates in the field, specifically as it relates to immunotherapies, immunology, and single-cell technologies
- Independently advise computational teams on matters of immunology
Requirements
Required qualifications
- Ph.D. in immunology or closely related field - A MUST
- A minimum of 4-6 years of related experience (postdoc or industry)
- Hands-on experience dealing with single-cell RNA sequencing including coding and data analysis in R (preferred) or Python - A MUST
- Experience with multimodal single-cell data such as CITE-seq, TCR/BCR-seq, or spatial approaches is a plus.
- Excellent communication and presentation skills
- Strong analytical skills, problem-solving ability, attention to detail, and innovation aptitude
- Excellent interpersonal skills and ability to work effectively as part of a team
- Excellent organization and time management skills, with an ability to multitask
- Ability to work independently with minimal supervision
Requirements
- Ph.D. in immunology or closely related field
- A minimum of 4-6 years of related experience (postdoc or industry)
- Hands-on experience with single-cell RNA sequencing including coding and data analysis in R or Python
- Experience with multimodal single-cell data such as CITE-seq, TCR/BCR-seq, or spatial approaches is a plus
- Excellent communication and presentation skills
- Strong analytical skills, problem-solving ability, attention to detail, and innovation aptitude
- Excellent interpersonal skills and ability to work effectively as part of a team
- Excellent organization and time management skills, with an ability to multitask
- Ability to work independently with minimal supervision
Company overview
Immunai is a pioneering biotechnology company that leverages artificial intelligence and single-cell genomics to decode the immune system for improved drug discovery and development. Founded in 2018 and headquartered in New York City with additional offices in Tel Aviv, Prague, and Zurich, the company has raised over $295 million in funding, achieving unicorn status in 2021. Immunai's core platform combines advanced machine learning with comprehensive single-cell multiomic profiling to create AMICA (Annotated Multiomic Immune Cell Atlas), the world's largest immune-focused database containing data from over 300,000 patient samples across 500+ diseases. The company's technology enables pharmaceutical partners to identify novel therapeutic targets, accelerate clinical trials, and improve patient outcomes by providing deep mechanistic insights into immune system responses. With a multidisciplinary team of over 80 PhDs, Immunai collaborates with leading academic institutions and biopharmaceutical companies to advance precision medicine in oncology, autoimmune diseases, and inflammatory conditions.